U.S. Breast Conserving Surgery Market Size, Share, Trends, Industry Analysis Report By Product Type (Lumpectomy Devices, Radiofrequency Ablation Devices), By Surgery Type, By End User, By Technology

Description

List of Tables

The U.S. breast conserving surgery market size is expected to reach USD 1,428.00 million by 2034, according to a new study by Polaris Market Research. The report "U.S. Breast Conserving Surgery Market Share, Size, Trends, Industry Analysis Report By Product Type (Lumpectomy Devices, Radiofrequency Ablation Devices), By Surgery Type, By End User, By Technology; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Breast conserving surgery (BCS), also known as lumpectomy or partial mastectomy, is used to remove cancerous tissue from the breast while preserving as much healthy tissue as possible. This approach is typically recommended for early-stage breast cancer patients where the tumor is relatively small compared to breast size. BCS is almost always followed by radiation therapy to eliminate any remaining cancer cells and reduce recurrence risk. The benefits of BCS include maintaining breast appearance, shorter recovery time, and less psychological impact compared to mastectomy. However, not all patients are candidates for BCS. Various factors such as tumor size, location, and multicentric disease influence eligibility.

In the U.S., breast conserving surgery (BCS) is a widely utilized treatment for early-stage breast cancer, supported by guidelines from organizations such as the National Comprehensive Cancer Network (NCCN). The U.S. healthcare system is emphasizing multidisciplinary care, combining BCS with radiation therapy in oncology based on individual risk factors. Advances in imaging and surgical techniques, such as oncoplastic surgery, have improved cosmetic outcomes, further increasing BCS adoption.

U.S. Breast Conserving Surgery Market Report Highlights

In terms of product type, the lumpectomy devices segment accounted for a major U.S. breast conserving surgery market revenue share in 2024 due to their widespread adoption as the standard surgical approach for early-stage breast cancer.

The radiofrequency ablation devices segment, based on product type, is projected to grow at a robust pace in the coming years, driven by its minimally invasive nature and increasing use among patients who are ineligible for traditional surgery.

Based on surgery type, the tumor lumpectomy segment held the largest U.S. breast conserving surgery market revenue share in 2024 due to its widespread acceptance as a first-line treatment for early-stage breast cancer.

In terms of end user, the hospitals segment dominated the revenue share in 2024 due to their advanced infrastructure, multidisciplinary care teams, and access to comprehensive diagnostic and therapeutic resources.

Based on technology, the traditional surgical techniques segment accounted for a major market share in 2024 due to their long-standing use, widespread surgeon familiarity, and proven clinical outcomes.

The image-guided surgery segment, in terms of technology, is projected to grow at a rapid pace during the assessment period owing to its ability to offer precision and real-time visualization in achieving clear margins and minimizing re-excisions.

A few key market players include Argon Medical Devices; CairnSurgical Inc.; Hologic, Inc; Innoblative Designs; KUBTEC; Lumicell Inc; Mammotome (Danaher); Merit Medical Systems; Perimeter Medical Imaging AI; and Stryker.

Polaris Market Research has segmented the U.S. breast conserving surgery market report on the basis of product type, surgery type, end user, and technology:

By Product Type Outlook (Revenue, USD Million, 2020-2034)

Lumpectomy Devices

Radiofrequency Ablation Devices

Cryoablation Devices

Microwave Ablation Devices

Others

By Surgery Type Outlook (Revenue, USD Million, 2020-2034)

Segmental Mastectomy

Quadrantectomy

Tumor Lumpectomy

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Ambulatory Surgical Centers (ASCs)

Specialty Clinics

Cancer Research Institutes

By Technology Outlook (Revenue, USD Million, 2020-2034)

Traditional Surgical Techniques

Image-guided Surgery

Robotic-assisted Surgery

Minimally Invasive Techniques

Product Code: PM6014

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. U.S. Breast Conserving Surgery Market Insights

4.1. Breast Conserving Surgery Market - Market Snapshot
4.2. Breast Conserving Surgery Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Incidence of Breast Cancer
  - 4.2.1.2. Growing Emphasis on Early Detection and Intervention
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulations Governing Radiation Therapy Protocols and Post-Operative Care Guidelines
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Breast Conserving Surgery Market Trends
4.6. Value Chain Analysis

5. U.S. Breast Conserving Surgery Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Breast Conserving Surgery Market, by Product Type, 2020-2034 (USD Million)
5.3. Lumpectomy Devices
- 5.3.1. U.S. Breast Conserving Surgery Market, by Lumpectomy Devices, by Region, 2020-2034 (USD Million)
5.4. Radiofrequency Ablation Devices
- 5.4.1. U.S. Breast Conserving Surgery Market, by Radiofrequency Ablation Devices, by Region, 2020-2034 (USD Million)
5.5. Cryoablation Devices
- 5.5.1. U.S. Breast Conserving Surgery Market, by Cryoablation Devices, by Region, 2020-2034 (USD Million)
5.6. Microwave Ablation Devices
- 5.6.1. U.S. Breast Conserving Surgery Market, by Microwave Ablation Devices, by Region, 2020-2034 (USD Million)
5.7. Others
- 5.7.1. U.S. Breast Conserving Surgery Market, by Others, by Region, 2020-2034 (USD Million)

6. U.S. Breast Conserving Surgery Market, by Surgery Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Breast Conserving Surgery Market, by Surgery Type, 2020-2034 (USD Million)
6.3. Segmental Mastectomy
- 6.3.1. U.S. Breast Conserving Surgery Market, by Segmental Mastectomy, by Region, 2020-2034 (USD Million)
6.4. Quadrantectomy
- 6.4.1. U.S. Breast Conserving Surgery Market, by Quadrantectomy, by Region, 2020-2034 (USD Million)
6.5. Tumor Lumpectomy
- 6.5.1. U.S. Breast Conserving Surgery Market, by Tumor Lumpectomy, by Region, 2020-2034 (USD Million)
6.6. Oncoplastic Surgery
- 6.6.1. U.S. Breast Conserving Surgery Market, by Oncoplastic Surgery, by Region, 2020-2034 (USD Million)

7. U.S. Breast Conserving Surgery Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. U.S. Breast Conserving Surgery Market, by End User, 2020-2034 (USD Million)
7.3. Hospitals
- 7.3.1. U.S. Breast Conserving Surgery Market, by Hospitals, by Region, 2020-2034 (USD Million)
7.4. Ambulatory Surgical Centers (ASCs)
- 7.4.1. U.S. Breast Conserving Surgery Market, by Ambulatory Surgical Centers (ASCs), by Region, 2020-2034 (USD Million)
7.5. Specialty Clinics
- 7.5.1. U.S. Breast Conserving Surgery Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
7.6. Cancer Research Institutes
- 7.6.1. U.S. Breast Conserving Surgery Market, by Cancer Research Institutes, by Region, 2020-2034 (USD Million)

8. U.S. Breast Conserving Surgery Market, by Technology

8.1. Key Findings
8.2. Introduction
- 8.2.1. U.S. Breast Conserving Surgery Market, by Technology, 2020-2034 (USD Million)
8.3. Traditional Surgical Techniques
- 8.3.1. U.S. Breast Conserving Surgery Market, by Traditional Surgical Techniques, by Region, 2020-2034 (USD Million)
8.4. Image-guided Surgery
- 8.4.1. U.S. Breast Conserving Surgery Market, by Image-guided Surgery, by Region, 2020-2034 (USD Million)
8.5. Robotic-assisted Surgery
- 8.5.1. U.S. Breast Conserving Surgery Market, by Robotic-assisted Surgery, by Region, 2020-2034 (USD Million)
8.6. Minimally Invasive Techniques
- 8.6.1. U.S. Breast Conserving Surgery Market, by Minimally Invasive Techniques, by Region, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Argon Medical Devices
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. BD
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. CairnSurgical Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Hologic, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Innoblative Designs
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. KUBTEC
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Mammotome (Danaher)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Merit Medical Systems
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Perimeter Medical Imaging AI
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Stryker
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development